We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Eyenovia Inc (EYEN) COM USD0.0001

Sell:$0.56 Buy:$0.59 Change: $0.0409 (7.54%)
Market closed |  Prices as at close on 24 April 2024 | Switch to live prices |
Sell:$0.56
Buy:$0.59
Change: $0.0409 (7.54%)
Market closed |  Prices as at close on 24 April 2024 | Switch to live prices |
Sell:$0.56
Buy:$0.59
Change: $0.0409 (7.54%)
Market closed |  Prices as at close on 24 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Eyenovia, Inc. is a commercial-stage ophthalmic pharmaceutical technology company developing a pipeline of microdose array print therapeutics based on its Optejet platform. It is focused on the commercialization of Mydcombi (tropicamide+phenylephrine ophthalmic spray) for mydriasis, as well as clobetasol propionate ophthalmic suspension 0.05% to reduce pain and inflammation following ocular surgery. Its product line includes Mydcombi, clobetasol propionate, and therapeutic programs, MicroPine and MicroLine. Mydcombi is its fixed combination formulation of tropicamide-phenylephrine for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroPine is its topical therapy for the treatment of progressive myopia, a disease associated with pathologic axial elongation of the eye and sclero-retinal stretching. MicroLine is its investigational pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens.

Contact details

Address:
295 Madison Ave Ste 2400
NEW YORK
10017
United States
Telephone:
+1 (813) 7669539
Website:
https://eyenovia.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
EYEN
ISIN:
US30234E1047
Market cap:
$26.32 million
Shares in issue:
50.96 million
Sector:
Pharmaceuticals
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Tsontcho Ianchulev
    Executive Chairman of the Board
  • Michael Rowe
    Chief Executive Officer, Director
  • John Gandolfo
    Chief Financial Officer, Secretary
  • Bren Kern
    Chief Operating Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.